Vertex Pharmaceuticals, Inc. (VRTX)
472.02
+2.12
(+0.45%)
USD |
NASDAQ |
Feb 02, 16:00
472.00
-0.02
(-0.00%)
After-Hours: 19:59
Vertex Pharmaceuticals Research and Development Expense (Quarterly) : 977.70M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 2.492B |
| Amgen, Inc. | 1.90B |
| Eli Lilly & Co. | 3.466B |
| Merck & Co., Inc. | 3.552B |
| Regeneron Pharmaceuticals, Inc. | 1.626B |